Qube Research & Technologies (QRT)’s Edwards Lifesciences EW Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$232K	Sell	2,900 -2,300	-44%	-$190K	﹤0.01%	2920
2025 Q4	$443K	Sell	5,200 -6,400	-55%	-$525K	﹤0.01%	2836
2025 Q3	$902K	Sell	11,600 -7,300	-39%	-$570K	﹤0.01%	2565
2025 Q2	$1.48M	Buy	18,900 +14,200	+302%	+$1.06M	﹤0.01%	2317
2025 Q1	$341K	Buy	4,700 +3,700	+370%	+$265K	﹤0.01%	2694
2024 Q4	$74K	Sell	1,000 -900	-47%	-$63K	﹤0.01%	3037
2024 Q3	$125K	Buy	+1,900	New	+$138K	﹤0.01%	2699
2023 Q4	–	Sell	-5,200	Closed	-$360K	–	4455
2023 Q3	$360K	Buy	+5,200	New	+$418K	﹤0.01%	2166

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Qube Research & Technologies (QRT)'s EW Position: Q1 2026 in Review

Qube Research & Technologies (QRT) reduced its Edwards Lifesciences (EW) stake by 29% in Q1 2026, selling an estimated $26.4M and leaving 795,188 shares worth $63.7M. The position accounts for 0.07% of the portfolio, ranked #339.

Qube Research & Technologies (QRT) first reported a position in EW in Q3 2018 and has held it in 22 quarters since. The position peaked at $95.1M in Q4 2025. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.

Qube Research & Technologies (QRT) held 795,188 shares of Edwards Lifesciences worth $63.7M as of Q1 2026.
Qube Research & Technologies (QRT) sold 320,036 Edwards Lifesciences shares in Q1 2026, an estimated $26.4M.
Edwards Lifesciences made up 0.07% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #339 holding.
Qube Research & Technologies (QRT) first reported a position in Edwards Lifesciences in Q3 2018 and has held it in 22 quarters since.
Qube Research & Technologies (QRT)'s Edwards Lifesciences position peaked at $95.1M in Q4 2025.
1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.